| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$202 |
FY25 results announcement
|
21 May 2025 8:27AM |
$0.835 |
$1.120 |
risen by
34.13%
|
|
PLT - Price-sensitive ASX Announcement
Full Release
Key Points
- Plenti achieved strong growth in loan origination volumes and overall loan book size.
- There is a continued focus on technology investments to improve operational efficiency and customer experience.
- Revenue increased year-on-year, driven by higher lending volumes and improved funding structures.
- Credit performance remains robust, with stringent risk management and low arrears.
- Expansion of funding sources included new warehouse facilities and strategic partnerships.
- Product innovation remains a core strategy, particularly in automotive and renewable energy finance.
- Plenti continues to prioritize digital transformation and scalable platform development.
- The company outlines a positive outlook based on market opportunities and internal capabilities.
- Operational leverage contributed to improved cost-to-income ratios.
- Strategic objectives include further automation, customer acquisition growth, and increased market penetration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Generation Australia Limited (FGX) ORDINARY FULLY PAID |
Financials |
$536 |
Annual General Meeting Chair's Address
|
21 May 2025 8:26AM |
$1.210 |
$1.305 |
risen by
7.85%
|
|
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$202 |
Corporate governance statement and Appendix 4G
|
21 May 2025 8:25AM |
$0.835 |
$1.120 |
risen by
34.13%
|
|
| Magontec Limited (MGL) ORDINARY FULLY PAID |
Materials |
$13 |
Minutes of AGM held on 7 May 2025
|
21 May 2025 8:25AM |
$0.200 |
$0.235 |
risen by
17.50%
|
|
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,525 |
Update - Notification of buy-back - KCN
|
21 May 2025 8:24AM |
$1.920 |
$5.760 |
risen by
200%
|
|
| COG Financial Services Limited (COG) ORDINARY FULLY PAID |
Financials |
$439 |
2025 EGM Letter to Shareholders, Notice of Meeting and Proxy
|
21 May 2025 8:24AM |
$1.370 |
$2.070 |
risen by
51.09%
|
|
| Duxton Water Limited (D2O) ORDINARY FULLY PAID |
Utilities |
$238 |
Update - Notification of buy-back - D2O
|
21 May 2025 8:24AM |
$1.520 |
$1.530 |
risen by
0.66%
|
|
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$202 |
FY25 annual report
|
21 May 2025 8:24AM |
$0.835 |
$1.120 |
risen by
34.13%
|
|
| COG Financial Services Limited (COG) ORDINARY FULLY PAID |
Financials |
$439 |
Update - Proposed issue of securities - COG
|
21 May 2025 8:24AM |
$1.370 |
$2.070 |
risen by
51.09%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$4,168 |
Update - Notification of buy-back - ZIP
|
21 May 2025 8:24AM |
$2.030 |
$3.280 |
risen by
61.58%
|
|
| Resimac Group Limited (RMC) ORDINARY FULLY PAID |
Financials |
$382 |
Resimac Acknowledges ASIC Proceedings
|
21 May 2025 8:24AM |
$0.850 |
$0.965 |
risen by
13.53%
|
|
RMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Resimac Group Limited acknowledges ASIC's Federal Court proceedings.
- Proceedings concern responsible lending obligations regarding home loans.
- Resimac is reviewing the ASIC proceedings and will cooperate.
- The company affirms its commitment to regulatory compliance.
- Resimac will update the market on any material developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$202 |
Preliminary final report Appendix 4E
|
21 May 2025 8:23AM |
$0.835 |
$1.120 |
risen by
34.13%
|
|
PLT - Price-sensitive ASX Announcement
Full Release
Key Points
- Plenti Group Limited released its Preliminary Final Report for the year ending 31 March 2024 (Appendix 4E).
- Plenti reported a 34% increase in revenue to $192.3 million and a 53% increase in loan portfolio to $2.13 billion.
- The company achieved a statutory net profit after tax (NPAT) of $6.0 million, a significant turnaround from a loss of $5.0 million in the previous year.
- The group generated a cash NPAT of $11.0 million, up from $2.7 million last year.
- Plenti’s loan originations grew by 30% to $1.5 billion, driven by growth in automotive, renewable energy, and personal lending divisions.
- Operating expenses increased by 13% to $53.7 million, mainly due to investments in technology and people to support growth.
- Credit performance remained strong, with 90+ day arrears at 46 basis points of the loan portfolio, highlighting robust credit management.
- The company reported cash and cash equivalents of $28.3 million as at 31 March 2024, with undrawn funding commitments of approximately $900 million.
- Plenti did not declare a dividend for the reporting period.
- The report includes comprehensive financial statements, notes to accounts, and commentary on the company’s strategy, outlook, and risk factors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$73 |
Urological Expert Appointed to LTR Scientific Advisory Board
|
21 May 2025 8:22AM |
$0.390 |
$0.650 |
risen by
66.67%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- LTR Pharma Ltd has appointed Professor Christopher Chapple to its Scientific Advisory Board.
- Professor Chapple is recognized as a leading expert in the field of urology.
- The appointment is intended to support the late-stage development of SPONTAN, LTR Pharma’s proprietary nasal spray formulation of sildenafil.
- SPONTAN aims to offer a fast-acting alternative for the treatment of erectile dysfunction.
- Professor Chapple’s role includes providing guidance on clinical programs, regulatory affairs, and strengthening ties with the urological community.
- The announcement underscores LTR Pharma’s commitment to advancing innovative treatments in men’s health.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$134 |
Update - Notification of buy-back - M7T
|
21 May 2025 8:22AM |
$0.375 |
$0.570 |
risen by
52%
|
|
| Skylark Minerals Limited (SKM) ORDINARY FULLY PAID |
Materials |
$22 |
Field Team Mobilised to Simon Project, Mt Isa
|
21 May 2025 8:22AM |
$0.180 |
$0.255 |
risen by
41.67%
|
|
SKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Skylark Minerals Limited (ASX: SKM) has mobilised its field team to the Simon Project near Mt Isa, Queensland.
- The Simon Project targets copper and critical minerals exploration.
- Initial fieldwork will include geological mapping, rock chip sampling, and planning for geophysical surveys.
- The project area is in proximity to established mining operations and infrastructure.
- SKM aims to identify and advance large-scale base metal deposits.
- The exploration program is designed to improve geological understanding and support future resource definition.
- This initiative marks a significant step forward in SKM’s exploration strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dalrymple Bay Infrastructure Limited (DBI) FULLY PAID ORDINARY/NOTES STAPLED SECURITIES |
Industrials |
$2,444 |
2025 Annual General Meeting
|
21 May 2025 8:22AM |
$4.090 |
$4.930 |
risen by
20.54%
|
|
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$10 |
Final Director's Interest Notice JW LB
|
21 May 2025 8:22AM |
$0.245 |
$0.115 |
fallen by
53.06%
|
|
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$29 |
NYR: Notice of Ceasing to be a Substantial Holder - NOX
|
21 May 2025 8:21AM |
$0.068 |
$0.099 |
risen by
45.59%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$280 |
Notice of Ceasing to be a Substantial Holder - NOX
|
21 May 2025 8:21AM |
$0.110 |
$1.150 |
risen by
945.45%
|
|
| Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$352 |
Update - Notification of buy-back - CVW
|
21 May 2025 8:21AM |
$0.485 |
$0.560 |
risen by
15.46%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$191 |
Ceasing to be a substantial holder
|
21 May 2025 8:21AM |
$0.021 |
$0.060 |
risen by
185.71%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$9 |
Proposed issue of securities - TEE
|
21 May 2025 8:21AM |
$0.066 |
$0.033 |
fallen by
50%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$390 |
Notification of cessation of securities - CGS
|
21 May 2025 8:21AM |
$1.340 |
$2.270 |
risen by
69.40%
|
|
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,185 |
Appointment of Director and Succession of Chair
|
21 May 2025 8:21AM |
$7.950 |
$8.850 |
risen by
11.32%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$390 |
Retirement of Non-Executive Director
|
21 May 2025 8:21AM |
$1.340 |
$2.270 |
risen by
69.40%
|
|